UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Medical Properties Trust, Inc. (NYSE:MPT - Free Report) by 301,176.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,539,997 shares of the company's stock after acquiring an additional 3,538,822 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.59% of Medical Properties Trust worth $16,355,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. OneAscent Family Office LLC acquired a new stake in Medical Properties Trust in the 2nd quarter worth approximately $49,000. Greenspring Advisors LLC purchased a new stake in Medical Properties Trust during the 2nd quarter worth approximately $54,000. Callan Family Office LLC acquired a new position in Medical Properties Trust during the 2nd quarter valued at approximately $66,000. Allworth Financial LP purchased a new position in shares of Medical Properties Trust in the second quarter worth $76,000. Finally, Sanctuary Advisors LLC acquired a new stake in shares of Medical Properties Trust during the second quarter worth $81,000. 71.79% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several research firms recently issued reports on MPT. Wells Fargo & Company cut their target price on Medical Properties Trust from $5.00 to $3.80 and set an "underweight" rating on the stock in a research report on Tuesday. Royal Bank Of Canada dropped their price target on Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating on the stock in a research note on Thursday, June 18th. Finally, Weiss Ratings lowered Medical Properties Trust from a "sell (d+)" rating to a "sell (d)" rating in a report on Tuesday, August 18th. One research analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Sell" and an average price target of $4.15.
Read Our Latest Report on Medical Properties Trust
Medical Properties Trust Trading Down 0.5%
Shares of NYSE MPT opened at $4.02 on Friday. The company has a debt-to-equity ratio of 2.16, a quick ratio of 3.12 and a current ratio of 3.12. Medical Properties Trust, Inc. has a 12 month low of $3.89 and a 12 month high of $6.47. The company's 50 day simple moving average is $4.44. The firm has a market cap of $2.40 billion, a PE ratio of -67.00 and a beta of 1.40.
Medical Properties Trust (NYSE:MPT - Get Free Report) last released its quarterly earnings data on Monday, August 10th. The company reported $0.15 EPS for the quarter, meeting the consensus estimate of $0.15. The business had revenue of $259.28 million for the quarter. Medical Properties Trust had a negative net margin of 2.96% and a negative return on equity of 0.66%. The firm's quarterly revenue was up 7.9% on a year-over-year basis. Analysts forecast that Medical Properties Trust, Inc. will post 0.6 EPS for the current year.
Medical Properties Trust Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 8th. Shareholders of record on Thursday, September 10th will be issued a $0.09 dividend. This represents a $0.36 annualized dividend and a yield of 9.0%. The ex-dividend date of this dividend is Thursday, September 10th. Medical Properties Trust's dividend payout ratio is presently -600.00%.
About Medical Properties Trust
(
Free Report)
Medical Properties Trust, Inc NYSE: MPT is a real estate investment trust (REIT) that acquires, owns and finances hospitals and other healthcare facilities. Founded in 2003 by Edward K. Aldag Jr., the company’s business model centers on providing real estate capital to healthcare operators through long-term leases, sale-leaseback transactions, build-to-suit developments and mortgage financing. By specializing in healthcare real estate, MPT aims to deliver steady rental income and asset-based returns while enabling operators to access capital for clinical operations and growth.
The company’s portfolio primarily comprises acute care hospitals, inpatient rehabilitation hospitals, long-term acute care facilities, behavioral health centers and other specialty hospitals.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.